USA - NASDAQ:INCY - US45337C1027 - Common Stock
We assign a fundamental rating of 6 out of 10 to INCY. INCY was compared to 534 industry peers in the Biotechnology industry. INCY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on INCY. These ratings would make INCY suitable for value and quality investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.96% | ||
| ROE | 20.88% | ||
| ROIC | 17.3% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.69% | ||
| PM (TTM) | 18.99% | ||
| GM | 93.41% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 8.35 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.85 | ||
| Quick Ratio | 2.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.56 | ||
| Fwd PE | 12.64 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.05 | ||
| EV/EBITDA | 13.76 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
93.48
+0.89 (+0.96%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.56 | ||
| Fwd PE | 12.64 | ||
| P/S | 3.98 | ||
| P/FCF | 19.05 | ||
| P/OCF | 18.2 | ||
| P/B | 4.38 | ||
| P/tB | 4.69 | ||
| EV/EBITDA | 13.76 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.96% | ||
| ROE | 20.88% | ||
| ROCE | 21.89% | ||
| ROIC | 17.3% | ||
| ROICexc | 47.5% | ||
| ROICexgc | 57.26% | ||
| OM | 21.69% | ||
| PM (TTM) | 18.99% | ||
| GM | 93.41% | ||
| FCFM | 20.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 49.5% | ||
| Cap/Sales | 0.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.43% | ||
| Profit Quality | 110.01% | ||
| Current Ratio | 2.85 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 8.35 |
ChartMill assigns a fundamental rating of 6 / 10 to INCY.
ChartMill assigns a valuation rating of 8 / 10 to INCYTE CORP (INCY). This can be considered as Undervalued.
INCYTE CORP (INCY) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for INCYTE CORP (INCY) is 14.56 and the Price/Book (PB) ratio is 4.38.
The Earnings per Share (EPS) of INCYTE CORP (INCY) is expected to grow by 378.66% in the next year.